Mar 22, 2017, 07:30 ET image

ProMIS Neurosciences Announces Appointment of Daniel Geffken as Chief Financial Officer

TSX: PMN TORONTO, March 22, 2017 /CNW/ - ProMIS Neurosciences ("ProMIS" or the "Company"), a company focused on the discovery and development of precision treatments for neurodegenerative diseases, today announced that it has appointed Daniel E. Geffken to the position of Chief Financial Officer. "We are pleased to welcome Daniel Geffken as his broad skill set and experience will contribute...

Mar 22, 2017, 14:26 ET

Chiropractic care is regulated and assures public safety

TORONTO, March 22, 2017 /CNW/ - Chiropractors are licensed and regulated by provincially-based colleges that act in...

Mar 22, 2017, 09:00 ET

Ontario Latest Province to Cover Cost of Immuno-Oncology Treatment OPDIVO® (nivolumab)

Eligible Ontario residents with difficult-to-treat advanced cancers can now access an innovative new treatment option...

Mar 22, 2017, 08:00 ET

Mayfair First Breast Imaging Practice in Alberta to Adopt Volpara® Enterprise™ Software

CALGARY, Alberta, March 22, 2017 /CNW/ -- Mayfair is the first medical imaging practice in Alberta to offer...